Ignite Creation Date:
2024-05-06 @ 7:31 PM
Last Modification Date:
2024-10-26 @ 3:08 PM
Study NCT ID:
NCT06040528
Status:
RECRUITING
Last Update Posted:
2023-09-15
First Post:
2022-12-22
Brief Title:
Early Discharge Pathway Registry
Sponsor:
Queen Mary University of London
Organization:
Queen Mary University of London
Study Overview
Official Title:
Barts Early Post-Acute Myocardial Infarction Discharge Registry
Status:
RECRUITING
Status Verified Date:
2022-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Despite the year-on-year decrease coronary artery disease CAD still remains one of the leading causes of mortality worldwide With advances in technology and our understanding of cardiac disease we can now treat CAD using minimally invasive interventional techniques This has revolutionised treatment for and improved the lives of many patients with CAD Although trials have assessed various therapeutic strategies in various populations real-world evidence of intervention and medical treatment among patients with CAD is increasingly recognised as an important part of providing safety and efficacy data and improving the care we provide
Regional heart attack services have improved clinical outcomes following ST-segment elevation myocardial infarction STEMI by facilitating early reperfusion by primary percutaneous coronary intervention PCI Early discharge after primary PCI is welcomed by patients and increases the efficiency of health care
This data will add to that literature by assessing the characteristics and outcomes of patients with CAD concentrating on those who are discharged via the early discharge pathway It will also identify and characterise predictors of outcomes and improve risk stratification and diagnostic evaluation
Regional heart attack services have improved clinical outcomes following ST-segment elevation myocardial infarction STEMI by facilitating early reperfusion by primary percutaneous coronary intervention PCI Early discharge after primary PCI is welcomed by patients and increases the efficiency of health care
This data will add to that literature by assessing the characteristics and outcomes of patients with CAD concentrating on those who are discharged via the early discharge pathway It will also identify and characterise predictors of outcomes and improve risk stratification and diagnostic evaluation
Detailed Description:
The proposed study includes one of the largest coronary interventional programmes in the UK at Europes largest cardiac centre BHC This has allowed us to accumulate a large number of patients in just over 4 years All patients admitted with acute coronary syndrome and discharged via the early discharge pathway are included in this study using a clinical database The database is password-protected and includes demographic clinical and outcome data
The database includes patients with simple to complex CAD We will use this database to test several hypotheses including but not limited to investigating characteristics of patients treated complications of interventional treatment and outcomes of patients This research will add substantially to the literature by providing real-world data from a leading coronary centre
In this registry we will assess the safety and feasibility of the EHD pathway for patients who were discharged after primary PCI from a high-volume heart attack centre in London
The impact of this study will have local regional and global consequences with an emphasis on investigating poorly studied areas eg decompensated aortic stenosis and providing evidence to improve their management and stimulate further research
The database includes patients with simple to complex CAD We will use this database to test several hypotheses including but not limited to investigating characteristics of patients treated complications of interventional treatment and outcomes of patients This research will add substantially to the literature by providing real-world data from a leading coronary centre
In this registry we will assess the safety and feasibility of the EHD pathway for patients who were discharged after primary PCI from a high-volume heart attack centre in London
The impact of this study will have local regional and global consequences with an emphasis on investigating poorly studied areas eg decompensated aortic stenosis and providing evidence to improve their management and stimulate further research
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None